Immuneering annual total assets
2020
2021
2022
2023
2024
2025
Immuneering Total Assets Growth & History (IMRX)
Immuneering's total assets was $232.0M for fiscal 2025.
View full Immuneering company overviewImmuneering annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $232.0M | $179.3M | +340.08% |
| 2024 | 2024-12-31 | $52.7M | −$49.9M | −48.61% |
| 2023 | 2023-12-31 | $102.6M | −$19.8M | −16.17% |
| 2022 | 2022-12-31 | $122.4M | −$44.3M | −26.60% |
| 2021 | 2021-12-31 | $166.7M | $128.3M | +333.87% |
| 2020 | 2020-12-31 | $38.4M | — | — |
Immuneering quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $202.1M | $162.0M | +404.43% |
| Q1 2026 | 2026-03-31 | $214.8M | $164.1M | +323.84% |
| Q4 2025 | 2025-12-31 | $232.0M | $179.3M | +340.08% |
| Q3 2025 | 2025-09-30 | $241.1M | $172.5M | +251.61% |
| Q2 2025 | 2025-06-30 | $40.1M | −$37.0M | −48.04% |
| Q1 2025 | 2025-03-31 | $50.7M | −$37.3M | −42.40% |
| Q4 2024 | 2024-12-31 | $52.7M | −$49.9M | −48.61% |
| Q3 2024 | 2024-09-30 | $68.6M | −$45.3M | −39.80% |
| Q2 2024 | 2024-06-30 | $77.1M | −$47.8M | −38.28% |
| Q1 2024 | 2024-03-31 | $88.0M | −$19.7M | −18.30% |
| Q4 2023 | 2023-12-31 | $102.6M | −$19.8M | −16.17% |
| Q3 2023 | 2023-09-30 | $113.9M | −$19.8M | −14.82% |
| Q2 2023 | 2023-06-30 | $124.9M | −$17.2M | −12.08% |
| Q1 2023 | 2023-03-31 | $107.7M | −$44.8M | −29.35% |
| Q4 2022 | 2022-12-31 | $122.4M | −$44.3M | −26.60% |
| Q3 2022 | 2022-09-30 | $133.7M | −$30.4M | −18.50% |
| Q2 2022 | 2022-06-30 | $142.0M | $89.0M | +167.81% |
| Q1 2022 | 2022-03-31 | $152.4M | — | — |
| Q4 2021 | 2021-12-31 | $166.7M | $128.3M | +333.87% |
| Q3 2021 | 2021-09-30 | $164.0M | — | — |
| Q2 2021 | 2021-06-30 | $53.0M | — | — |
| Q4 2020 | 2020-12-31 | $38.4M | — | — |
Immuneering total assets trends
Over the last five fiscal years, Immuneering's total assets increased from $38.4M to $232.0M, a change of $193.6M. The latest reported quarter, Q2 2026, shows $202.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immuneering source filings ↗